Enovis to Participate in Upcoming Investor Conferences
Enovis (NYSE: ENOV) has announced its management team's participation in two upcoming investor conferences. At the Jefferies London Healthcare Conference, Chair and CEO Matt Trerotola and CFO Ben Berry will join a fireside chat on November 20th at 12:00 p.m. GMT. Subsequently, CFO Ben Berry will participate in the Evercore 7th Annual HealthCONx Conference on December 4th at 10:50 a.m. ET.
Both events will be available via live audio webcasts and replays on the company's website under the Investors tab. Enovis is a medical technology growth company focused on developing clinically differentiated solutions for better patient outcomes and workflow transformation in orthopedics and beyond.
Enovis (NYSE: ENOV) ha annunciato la partecipazione del suo team di gestione a due prossime conferenze per investitori. Al Jefferies London Healthcare Conference, il Chair e CEO Matt Trerotola e il CFO Ben Berry parteciperanno a una chiacchierata informale il 20 novembre alle 12:00 GMT. Successivamente, il CFO Ben Berry parteciperà al Evercore 7th Annual HealthCONx Conference il 4 dicembre alle 10:50 ET.
Entrambi gli eventi saranno disponibili tramite webcast audio in diretta e registrazioni sul sito web dell'azienda sotto la sezione Investitori. Enovis è un'azienda di tecnologia medica in crescita, focalizzata sullo sviluppo di soluzioni clinicamente differenziate per migliorare i risultati dei pazienti e trasformare il flusso di lavoro in ortopedia e oltre.
Enovis (NYSE: ENOV) ha anunciado la participación de su equipo de gestión en dos próximas conferencias para inversores. En la Jefferies London Healthcare Conference, el Presidente y CEO Matt Trerotola y el CFO Ben Berry participarán en un chat al lado de la chimenea el 20 de noviembre a las 12:00 p.m. GMT. Posteriormente, el CFO Ben Berry participará en la Evercore 7th Annual HealthCONx Conference el 4 de diciembre a las 10:50 a.m. ET.
Ambos eventos estarán disponibles a través de transmisiones web en vivo de audio y repeticiones en el sitio web de la empresa en la pestaña de Inversores. Enovis es una empresa de tecnología médica en crecimiento centrada en desarrollar soluciones clínicamente diferenciadas para obtener mejores resultados para los pacientes y transformar el flujo de trabajo en ortopedia y más allá.
Enovis (NYSE: ENOV)는 경영진 팀의 두 가지 투자자 회의 참석을 발표했습니다. Jefferies London Healthcare Conference에서 의장 겸 CEO Matt Trerotola와 CFO Ben Berry는 11월 20일 GMT 12:00에 진행되는 대화에 참석할 예정입니다. 이후 CFO Ben Berry는 12월 4일 ET 10:50에 Evercore 7th Annual HealthCONx Conference에 참석할 것입니다.
두 이벤트 모두 회사 웹사이트의 투자자 탭에서 라이브 오디오 웹캐스트와 재생으로 이용할 수 있습니다. Enovis는 임상적으로 차별화된 솔루션을 개발하여 환자 결과와 정형외과 및 그 너머의 워크플로우 변화를 개선하는 데 중점을 둔 의료 기기 성장 회사입니다.
Enovis (NYSE: ENOV) a annoncé la participation de son équipe de direction à deux prochaines conférences pour investisseurs. Lors de la Jefferies London Healthcare Conference, le président et CEO Matt Trerotola et le CFO Ben Berry participeront à une discussion informelle le 20 novembre à 12h00 GMT. Par la suite, le CFO Ben Berry participera à la Evercore 7th Annual HealthCONx Conference le 4 décembre à 10h50 ET.
Les deux événements seront disponibles via des webcasts audio en direct et des rediffusions sur le site web de l'entreprise dans l'onglet Investisseurs. Enovis est une entreprise de technologie médicale en croissance, axée sur le développement de solutions cliniquement différenciées pour de meilleurs résultats pour les patients et la transformation des flux de travail en orthopédie et au-delà.
Enovis (NYSE: ENOV) hat die Teilnahme seines Management-Teams an zwei bevorstehenden Investorenkonferenzen bekannt gegeben. Auf der Jefferies London Healthcare Conference werden der Vorsitzende und CEO Matt Trerotola sowie CFO Ben Berry am 20. November um 12:00 Uhr GMT an einem informellen Gespräch teilnehmen. Anschließend wird CFO Ben Berry am 4. Dezember um 10:50 Uhr ET an der Evercore 7th Annual HealthCONx Conference teilnehmen.
Beide Veranstaltungen werden über Live-Audio-Webcasts und Aufzeichnungen auf der Unternehmenswebsite im Bereich Investoren verfügbar sein. Enovis ist ein wachsendes Unternehmen im Bereich Medizintechnologie, das sich auf die Entwicklung klinisch differenzierter Lösungen zur Verbesserung der Patientenergebnisse und zur Transformation von Arbeitsabläufen in der Orthopädie und darüber hinaus konzentriert.
- None.
- None.
Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:
- Jefferies London Healthcare Conference: Matt Trerotola, Chair and Chief Executive Officer, and Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, November 20th at 12:00 p.m. GMT (7:00 a.m. ET)
- Evercore 7th Annual HealthCONx Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, December 4th at 10:50 a.m. ET.
A link to the live audio webcasts, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com
FAQ
When is Enovis (ENOV) presenting at the Jefferies London Healthcare Conference?
Who will represent Enovis (ENOV) at the Evercore HealthCONx Conference?
Where can investors watch Enovis (ENOV) conference presentations?
What upcoming investor conferences will Enovis (ENOV) attend in 2024?
